Skip to main content
. 2019 Nov 14;10:1332. doi: 10.3389/fphar.2019.01332

Figure 1.

Figure 1

LGS suppresses the release of IL-6 in LPS-induced RAW264.7 cells. (A) LGS (50−200 μg/ml) has no obvious cytotoxicity in RAW264.7 macrophage cells. The cell cytotoxicity of LGS was confirmed by MTT assay. (B) LGS inhibits the production of IL-6 in LPS-induced RAW264.7 cells. Macrophages were cultivated with LGS (200 μg/ml) or dexamethasone (DEX, as a positive control) (100 μM) in the presence of LPS (1 μg/ml) for 24 h. The level of IL-6 in supernatants was analyzed by ELISA. Data are represented as the mean ± SEM of three independent experiments. ### P < 0.001 versus control, **P < 0.01, ***P < 0.001 versus LPS treatment by one-way ANOVA with Tukey’s test.